Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled trial of human umbilical cord mesenchymal stem cell injection for knee osteoarthritis
CTR20252299Phase 2Active
- Sponsor
- Wuhan Hamilton Biotechnology
- Start
- Jul 2025
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in knee osteoarthritis (OA) comparing Human umbilical cord mesenchymal stem cell injection with Vehicle control (2 arms). Primary endpoint: Change from baseline in WOMAC total score. Started Jul 2025; status: active.
02
Drugs
human umbilical cord mesenchymal stem cell
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on CTR20252299.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20252299.